-
Je něco špatně v tomto záznamu ?
Expiratory Muscle Strength Training in Multiple System Atrophy: A Pilot Study
M. Srp, T. Bartosova, J. Klempir, R. Lagnerova, O. Gal, T. Listvanova, R. Jech, E. Ruzicka, M. Hoskovcova
Status neindexováno Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
PubMed Central
od 2014 do Před 1 rokem
Europe PubMed Central
od 2014 do Před 1 rokem
PubMed
37476315
DOI
10.1002/mdc3.13765
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
BACKGROUND: The effects of expiratory muscle strength training (EMST) has not yet been investigated in MSA patients. OBJECTIVE: The primary objective was to test the effects of EMST on expiratory muscle strength and voluntary peak cough flow (vPCF) in patients with multiple system atrophy (MSA). The secondary objective was to assess the suitability of the pulmonary dysfunction index as a tool for identifying MSA patients with expiratory muscle weakness and reduced voluntary peak cough flow. METHODS: This was an open label, non-controlled study, with an 8-week intensive home-based EMST protocol. The outcome measures included: maximal expiratory pressure (MEP) and vPCF. The sensitivity and specificity of the index of pulmonary dysfunction in the respiratory diagnostic process were assessed using receiver operating characteristic (ROC) analysis. RESULTS: Fifteen MSA patients were enrolled in the study. Twelve MSA patients completed the training period. After the training period, MEP significantly increased (P = 0.006). Differences in vPCF were not significant (P = 0.845). ROC analysis indicated that the overall respiratory diagnostic accuracy of the index of pulmonary dysfunction had an outstanding capability to detect patients at risk of less effective coughing and an acceptable capability of detecting patients with decreased expiratory muscle strength. CONCLUSIONS: These findings indicate non-significant differences in vPCF after 8 weeks of EMST. The index of pulmonary dysfunction appears to be a promising prognostic screening tool for identifying altered cough efficacy in MSA patients. Test cut-offs may be used to select an appropriate respiratory physiotherapy technique.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23015809
- 003
- CZ-PrNML
- 005
- 20231020093601.0
- 007
- ta
- 008
- 231010s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/mdc3.13765 $2 doi
- 035 __
- $a (PubMed)37476315
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Srp, Martin $u Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine, Charles University and General University Hospital in Prague Prague Czech Republic
- 245 10
- $a Expiratory Muscle Strength Training in Multiple System Atrophy: A Pilot Study / $c M. Srp, T. Bartosova, J. Klempir, R. Lagnerova, O. Gal, T. Listvanova, R. Jech, E. Ruzicka, M. Hoskovcova
- 520 9_
- $a BACKGROUND: The effects of expiratory muscle strength training (EMST) has not yet been investigated in MSA patients. OBJECTIVE: The primary objective was to test the effects of EMST on expiratory muscle strength and voluntary peak cough flow (vPCF) in patients with multiple system atrophy (MSA). The secondary objective was to assess the suitability of the pulmonary dysfunction index as a tool for identifying MSA patients with expiratory muscle weakness and reduced voluntary peak cough flow. METHODS: This was an open label, non-controlled study, with an 8-week intensive home-based EMST protocol. The outcome measures included: maximal expiratory pressure (MEP) and vPCF. The sensitivity and specificity of the index of pulmonary dysfunction in the respiratory diagnostic process were assessed using receiver operating characteristic (ROC) analysis. RESULTS: Fifteen MSA patients were enrolled in the study. Twelve MSA patients completed the training period. After the training period, MEP significantly increased (P = 0.006). Differences in vPCF were not significant (P = 0.845). ROC analysis indicated that the overall respiratory diagnostic accuracy of the index of pulmonary dysfunction had an outstanding capability to detect patients at risk of less effective coughing and an acceptable capability of detecting patients with decreased expiratory muscle strength. CONCLUSIONS: These findings indicate non-significant differences in vPCF after 8 weeks of EMST. The index of pulmonary dysfunction appears to be a promising prognostic screening tool for identifying altered cough efficacy in MSA patients. Test cut-offs may be used to select an appropriate respiratory physiotherapy technique.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bartosova, Tereza $u Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine, Charles University and General University Hospital in Prague Prague Czech Republic
- 700 1_
- $a Klempir, Jiri $u Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine, Charles University and General University Hospital in Prague Prague Czech Republic
- 700 1_
- $a Lagnerova, Rebeka $u Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine, Charles University and General University Hospital in Prague Prague Czech Republic
- 700 1_
- $a Gal, Ota $u Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine, Charles University and General University Hospital in Prague Prague Czech Republic
- 700 1_
- $a Listvanova, Tereza $u Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine, Charles University and General University Hospital in Prague Prague Czech Republic
- 700 1_
- $a Jech, Robert $u Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine, Charles University and General University Hospital in Prague Prague Czech Republic $1 https://orcid.org/0000000297328947 $7 xx0082225
- 700 1_
- $a Ruzicka, Evzen $u Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine, Charles University and General University Hospital in Prague Prague Czech Republic
- 700 1_
- $a Hoskovcova, Martina $u Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine, Charles University and General University Hospital in Prague Prague Czech Republic
- 773 0_
- $w MED00197327 $t Movement disorders clinical practice $x 2330-1619 $g Roč. 10, č. 7 (2023), s. 1060-1065
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37476315 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231010 $b ABA008
- 991 __
- $a 20231020093555 $b ABA008
- 999 __
- $a ok $b bmc $g 1997276 $s 1202171
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 10 $c 7 $d 1060-1065 $e 20230519 $i 2330-1619 $m Movement disorders clinical practice $n Mov Disord Clin Pract $x MED00197327
- LZP __
- $a Pubmed-20231010